NASDAQ:NPSP NPS Pharmaceuticals (NPSP) Stock Price, News & Analysis → Will this $2 AI stock double overnight? (From Behind the Markets) (Ad) Free NPSP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get NPS Pharmaceuticals alerts: Email Address Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> About NPS Pharmaceuticals Stock (NASDAQ:NPSP)NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company focused on delivering therapies that transform the lives of patients with rare diseases. The Company’s primary product Gattex 0.05 mg/kg/d (teduglutide [rDNA origin]) for injection, for subcutaneous use was approved the United States Food and Drug Administration (FDA) for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on parenteral support. The Company’s second principal product, Natpara (recombinant human parathyroid hormone 1-84 [rDNA origin] injection, has been developed for hypoparathyroidism, a rare multidimensional disorder characterized by deficient or absent parathyroid hormone (PTH). The Company has collaborations or royalty agreements with Amgen, Janssen, GlaxoSmithKline and Kyowa Hakko Kirin.Read More Ad Behind the MarketsWill this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!Click here to learn more >>> NPSP Stock News HeadlinesNovember 14, 2023 | forbes.comArena PharmaceuticalsOctober 18, 2023 | investing.comNPSP Historical DataApril 25, 2024 | Behind the Markets (Ad)Will this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!March 31, 2023 | thestreet.comNPS Stock Gaps Down On Today's Open (NPSP)February 13, 2023 | msn.comHow to reclaim withdrawn but unclaimed amount from National Pension System (NPS) accountDecember 15, 2022 | msn.comHow much money is held under National Pension System (NPS): State-wise data hereOctober 6, 2022 | msn.comNPS proposes systematic lump sum withdrawal plan for pensioners; invites suggestions till 19 OctoberSeptember 21, 2022 | thestreet.comNPS Pharma: Bullish Options Trade Into the Gattex FDA PanelApril 25, 2024 | Behind the Markets (Ad)Will this $2 AI stock double overnight?It's a tiny AI company fighting for a big piece of a $20 Billion Pentagon contract. What's more, this groundbreaking firm is trading for less than $2 a share!September 9, 2022 | msn.comNPS Calculator: Want Rs 75,000 monthly pension post retirement? Here’s how much you need to investJuly 18, 2022 | thestreet.comEnzon and NPS Pharma Call Off MergerJune 28, 2022 | msn.comNPS Pension Calculator: Now you can get Rs 2 lakh per month, here's howMay 4, 2022 | thestreet.comCramer's 'Mad Money' Recap: The Winning FormulaFebruary 20, 2022 | forbes.comKrispy Kreme Doughnuts (DNUT)January 7, 2022 | thestreet.comEuropean Stocks Rebound as Pharma Deals Renew ConfidenceOctober 26, 2021 | finance.yahoo.comCelgene and NPS Pharmaceuticals Shares Surge on Positive FDA NewsSee More Headlines Receive NPSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NPS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/18/2015Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryBiotechnology Current SymbolNASDAQ:NPSP CUSIP62936P10 CIK890465 Webwww.npsp.com Phone+1-908-4505300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report NPSP Stock Analysis - Frequently Asked Questions How were NPS Pharmaceuticals' earnings last quarter? NPS Pharmaceuticals Inc (NASDAQ:NPSP) released its earnings results on Wednesday, February, 18th. The biopharmaceutical company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of $0.06 by $0.08. The biopharmaceutical company earned $66.70 million during the quarter, compared to analysts' expectations of $69.30 million. What other stocks do shareholders of NPS Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other NPS Pharmaceuticals investors own include Gilead Sciences (GILD), General Electric (ge), Intercept Pharmaceuticals (ICPT), Pharmacyclics (PCYC), Pfizer (PFE), Alkermes (ALKS), 3D Systems (DDD), FireEye (FEYE) and GW Pharmaceuticals (GWPH). This page (NASDAQ:NPSP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyI’m afraid WWIII is a very real possibility Porter & CompanyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NPS Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
